
Magdalene K. Sgagias
Examiner (ID: 4537, Phone: (571)272-3305 , Office: P/1632 )
| Most Active Art Unit | 1632 |
| Art Unit(s) | 1632 |
| Total Applications | 637 |
| Issued Applications | 229 |
| Pending Applications | 42 |
| Abandoned Applications | 366 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 8697376
[patent_doc_number] => 20130059385
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-03-07
[patent_title] => 'METHODS OF GENERATING PLURIPOTENT STEM CELLS'
[patent_app_type] => utility
[patent_app_number] => 13/582011
[patent_app_country] => US
[patent_app_date] => 2010-03-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 13899
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13582011
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/582011 | METHODS OF GENERATING PLURIPOTENT STEM CELLS | Mar 1, 2010 | Abandoned |
Array
(
[id] => 6556287
[patent_doc_number] => 20100222877
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-09-02
[patent_title] => 'Tissue Engineered Human Pulmonary Valves with Cyclic Pressure Bioreactor Accelerated Seeding Strategies and Methods For Assessing Inflammatory Potential of Putative Scaffolds for Tissue Engineered Heart Valves'
[patent_app_type] => utility
[patent_app_number] => 12/716253
[patent_app_country] => US
[patent_app_date] => 2010-03-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 26
[patent_no_of_words] => 21112
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0222/20100222877.pdf
[firstpage_image] =>[orig_patent_app_number] => 12716253
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/716253 | Tissue Engineered Human Pulmonary Valves with Cyclic Pressure Bioreactor Accelerated Seeding Strategies and Methods For Assessing Inflammatory Potential of Putative Scaffolds for Tissue Engineered Heart Valves | Mar 1, 2010 | Abandoned |
Array
(
[id] => 6320869
[patent_doc_number] => 20100196441
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-08-05
[patent_title] => 'USES OF IMMUNOLOGICALLY MODIFIED SCAFFOLD FOR TISSUE PREVASCULARIZATION CELL TRANSPLANTATION'
[patent_app_type] => utility
[patent_app_number] => 12/699426
[patent_app_country] => US
[patent_app_date] => 2010-02-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 11770
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0196/20100196441.pdf
[firstpage_image] =>[orig_patent_app_number] => 12699426
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/699426 | USES OF IMMUNOLOGICALLY MODIFIED SCAFFOLD FOR TISSUE PREVASCULARIZATION CELL TRANSPLANTATION | Feb 2, 2010 | Abandoned |
Array
(
[id] => 6250105
[patent_doc_number] => 20100137676
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-06-03
[patent_title] => 'N-ACETYLCYSTEINE AMIDE (NAC AMIDE) FOR TREATMENT OF OXIDATIVE STRESS ASSOCIATED WITH INFERTILITY'
[patent_app_type] => utility
[patent_app_number] => 12/696399
[patent_app_country] => US
[patent_app_date] => 2010-01-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12005
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0137/20100137676.pdf
[firstpage_image] =>[orig_patent_app_number] => 12696399
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/696399 | N-ACETYLCYSTEINE AMIDE (NAC AMIDE) FOR TREATMENT OF OXIDATIVE STRESS ASSOCIATED WITH INFERTILITY | Jan 28, 2010 | Abandoned |
Array
(
[id] => 6265235
[patent_doc_number] => 20100297731
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-11-25
[patent_title] => 'Novel adenoviruses, nucleic acids that code for the same and the use of said viruses'
[patent_app_type] => utility
[patent_app_number] => 12/690729
[patent_app_country] => US
[patent_app_date] => 2010-01-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 34
[patent_figures_cnt] => 34
[patent_no_of_words] => 44549
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0297/20100297731.pdf
[firstpage_image] =>[orig_patent_app_number] => 12690729
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/690729 | Adenoviruses, nucleic acids that code for the same and the use of said viruses | Jan 19, 2010 | Issued |
Array
(
[id] => 7671913
[patent_doc_number] => 20110321182
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-12-29
[patent_title] => 'SELECTION OF ANIMALS FOR DESIRED MILK AND/OR TISSUE PROFILE'
[patent_app_type] => utility
[patent_app_number] => 13/142092
[patent_app_country] => US
[patent_app_date] => 2009-12-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 30314
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13142092
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/142092 | SELECTION OF ANIMALS FOR DESIRED MILK AND/OR TISSUE PROFILE | Dec 23, 2009 | Abandoned |
Array
(
[id] => 6648619
[patent_doc_number] => 20100175140
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-07-08
[patent_title] => 'Leucine-rich repeat kinase (LRRK2) drosophila model for parkinson\'s disease: wildtype1 (WT1) and G2019S mutant flies'
[patent_app_type] => utility
[patent_app_number] => 12/653986
[patent_app_country] => US
[patent_app_date] => 2009-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 9639
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0175/20100175140.pdf
[firstpage_image] =>[orig_patent_app_number] => 12653986
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/653986 | Leucine-rich repeat kinase (LRRK2) drosophila model for parkinson's disease: wildtype1 (WT1) and G2019S mutant flies | Dec 20, 2009 | Abandoned |
Array
(
[id] => 7669161
[patent_doc_number] => 20110318430
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-12-29
[patent_title] => 'TUMOR THERAPY WITH ANTITUMOR AGENTS IN COMBINATION WITH SINDBIS VIRUS-BASED VECTORS'
[patent_app_type] => utility
[patent_app_number] => 13/133680
[patent_app_country] => US
[patent_app_date] => 2009-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 13659
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13133680
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/133680 | TUMOR THERAPY WITH ANTITUMOR AGENTS IN COMBINATION WITH SINDBIS VIRUS-BASED VECTORS | Dec 17, 2009 | Abandoned |
Array
(
[id] => 7651958
[patent_doc_number] => 20110301227
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-12-08
[patent_title] => 'PROLIFERATION-ASSOCIATED MODULATION OF THE SPLICING OF THE INTEGRIN ALPHA 6 ISOFORMS'
[patent_app_type] => utility
[patent_app_number] => 13/139262
[patent_app_country] => US
[patent_app_date] => 2009-12-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 15268
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0301/20110301227.pdf
[firstpage_image] =>[orig_patent_app_number] => 13139262
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/139262 | PROLIFERATION-ASSOCIATED MODULATION OF THE SPLICING OF THE INTEGRIN ALPHA 6 ISOFORMS | Dec 9, 2009 | Abandoned |
Array
(
[id] => 9626556
[patent_doc_number] => 08796236
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-08-05
[patent_title] => 'Gene therapy for lysosomal storage diseases'
[patent_app_type] => utility
[patent_app_number] => 12/631336
[patent_app_country] => US
[patent_app_date] => 2009-12-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 11327
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 81
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12631336
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/631336 | Gene therapy for lysosomal storage diseases | Dec 3, 2009 | Issued |
Array
(
[id] => 9983627
[patent_doc_number] => 09029336
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-05-12
[patent_title] => 'Xenobiotic related induction of gene expression'
[patent_app_type] => utility
[patent_app_number] => 12/629186
[patent_app_country] => US
[patent_app_date] => 2009-12-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 6682
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 116
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12629186
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/629186 | Xenobiotic related induction of gene expression | Dec 1, 2009 | Issued |
Array
(
[id] => 7582657
[patent_doc_number] => 20110296540
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-12-01
[patent_title] => 'ASSAY FOR SCREENING ANTIDEPRESSANTS'
[patent_app_type] => utility
[patent_app_number] => 13/131558
[patent_app_country] => US
[patent_app_date] => 2009-12-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 30
[patent_figures_cnt] => 30
[patent_no_of_words] => 33309
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0296/20110296540.pdf
[firstpage_image] =>[orig_patent_app_number] => 13131558
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/131558 | ASSAY FOR SCREENING ANTIDEPRESSANTS | Nov 30, 2009 | Abandoned |
Array
(
[id] => 7569542
[patent_doc_number] => 20110289605
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-11-24
[patent_title] => 'Animal Model for Osteoarthritis and Intervertebral Disc Disease'
[patent_app_type] => utility
[patent_app_number] => 13/130490
[patent_app_country] => US
[patent_app_date] => 2009-11-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 30
[patent_figures_cnt] => 30
[patent_no_of_words] => 14667
[patent_no_of_claims] => 64
[patent_no_of_ind_claims] => 27
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0289/20110289605.pdf
[firstpage_image] =>[orig_patent_app_number] => 13130490
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/130490 | Animal Model for Osteoarthritis and Intervertebral Disc Disease | Nov 24, 2009 | Abandoned |
Array
(
[id] => 6007495
[patent_doc_number] => 20110059526
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-03-10
[patent_title] => 'REPROGRAMMING A CELL BY INDUCING A PLURIPOTENT GENE THROUGH USE OF AN HDAC MODULATOR'
[patent_app_type] => utility
[patent_app_number] => 12/616983
[patent_app_country] => US
[patent_app_date] => 2009-11-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 16757
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0059/20110059526.pdf
[firstpage_image] =>[orig_patent_app_number] => 12616983
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/616983 | REPROGRAMMING A CELL BY INDUCING A PLURIPOTENT GENE THROUGH USE OF AN HDAC MODULATOR | Nov 11, 2009 | Abandoned |
Array
(
[id] => 6356622
[patent_doc_number] => 20100087002
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-04-08
[patent_title] => 'Methods, Surface Modified Plates and Compositions for Cell Attachment, Cultivation and Detachment'
[patent_app_type] => utility
[patent_app_number] => 12/608584
[patent_app_country] => US
[patent_app_date] => 2009-10-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 53
[patent_figures_cnt] => 53
[patent_no_of_words] => 31377
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0087/20100087002.pdf
[firstpage_image] =>[orig_patent_app_number] => 12608584
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/608584 | Methods, Surface Modified Plates and Compositions for Cell Attachment, Cultivation and Detachment | Oct 28, 2009 | Abandoned |
Array
(
[id] => 8477217
[patent_doc_number] => 20120276625
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-11-01
[patent_title] => 'METHOD FOR PRODUCING MESENCHYMAL STEM CELLS FROM HUMAN PLURIPOTENT STEM CELLS, AND MESENCHYMAL STEM CELLS PRODUCED BY SAME'
[patent_app_type] => utility
[patent_app_number] => 13/504881
[patent_app_country] => US
[patent_app_date] => 2009-10-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 7369
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13504881
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/504881 | Mesenchymal stem cells produced from human pluripotent stem cells | Oct 27, 2009 | Issued |
Array
(
[id] => 7662229
[patent_doc_number] => 20110311498
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-12-22
[patent_title] => 'GENERATION OF PATIENT-SPECIFIC DIFFERENTIATED CELL TYPES BY EPIGENETIC INDUCTION'
[patent_app_type] => utility
[patent_app_number] => 12/998381
[patent_app_country] => US
[patent_app_date] => 2009-10-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 12229
[patent_no_of_claims] => 56
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0311/20110311498.pdf
[firstpage_image] =>[orig_patent_app_number] => 12998381
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/998381 | Generation of patient-specific differentiated cell types by epigenetic induction | Oct 25, 2009 | Issued |
Array
(
[id] => 11922918
[patent_doc_number] => 09790489
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-10-17
[patent_title] => 'Method for performing genetic modification under a drug-free environment and components thereof'
[patent_app_type] => utility
[patent_app_number] => 12/588708
[patent_app_country] => US
[patent_app_date] => 2009-10-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 8
[patent_no_of_words] => 6506
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 320
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12588708
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/588708 | Method for performing genetic modification under a drug-free environment and components thereof | Oct 25, 2009 | Issued |
Array
(
[id] => 7499507
[patent_doc_number] => 20110262465
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-10-27
[patent_title] => 'PROSTATE STEM CELLS AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 13/124428
[patent_app_country] => US
[patent_app_date] => 2009-10-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 21106
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0262/20110262465.pdf
[firstpage_image] =>[orig_patent_app_number] => 13124428
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/124428 | PROSTATE STEM CELLS AND USES THEREOF | Oct 20, 2009 | Abandoned |
Array
(
[id] => 9126617
[patent_doc_number] => 08574564
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-11-05
[patent_title] => 'Immunostimulatory nucleic acid packaged particles for the treatment of hypersensitivity'
[patent_app_type] => utility
[patent_app_number] => 12/576086
[patent_app_country] => US
[patent_app_date] => 2009-10-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 54332
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 98
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12576086
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/576086 | Immunostimulatory nucleic acid packaged particles for the treatment of hypersensitivity | Oct 7, 2009 | Issued |